According to our new research study on “Biosimilars Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Disease Indication, Drug Class, Route of Administration, and End User,” the biosimilars market is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028; it is estimated to record a CAGR of 34.8% during...